WPRIM Management System> DCMS> Journal of Breast Cancer> 2019> 22> 3

Volume: 22 Issue: 3

1. Primary Histiocytic Sarcoma Presenting as a Breast Mass: A Case Report Page:491—496
2. Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma Page:484—490
3. Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insertion in Breast Cancer Patients: A Retrospective Case-control Study Page:472—483
4. Gastric Complications after Adjuvant Radiotherapy for Breast Cancer Page:464—471
5. Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer Page:453—463
6. Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value Page:439—452
7. The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Page:425—438
8. Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype⁻ Breast Cancer Page:412—424
9. Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer Page:399—411
10. Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen Page:387—398
11. In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer Page:375—386
12. Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling Page:362—374
13. Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer Page:341—361

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.